Emapalumab (NI-0501) is a human monoclonal IgG1 antibody that noncompetitively inhibits IFN-gamma. Emapalumab binds with high affinity (Kd= 1.4 pM) to both free IFN-gamma as well as IFN-gamma bound to its receptor. Emapalumab can be used in research of hemophagocytic lymphohistiocytosis (HLH)[1].
Molecular Weight:
(145.22 kDa)
Purity:
98.86
CAS Number:
[1709815-23-5]
Target:
IFNAR
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted